The latest news from oncology events around the world
Adding the targeted therapy drug ribociclib to hormonal (endocrine) therapy showed a significant improvement in…
The NCCN 2023 Annual Conference took place in-person in Orlando and virtually, with a particular…
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete…
Results from the S1609 DART clinical trial, which tested an immunotherapy combination of ipilimumab plus…
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that…
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging response rates and…
Tisch Cancer Center scientists developed unique models of the deadliest blood cancer, acute myeloid leukaemia…
Vinita Takiar’s lab in UC’s Department of Radiation Oncology studies how to improve radiation therapy…
Written by Dr Michelle Wilson, Medical Oncologist & ANZGOG New Zealand Director Introduction The Australia…
If there is one thing a cancer patient wants beyond fast, effective treatment – it…